372 related articles for article (PubMed ID: 10223227)
21. Amplification and expression of c-MET correlate with poor prognosis of patients with gastric cancer and upregulate the expression of PDL1.
Yang Y; Wang C; Dai C; Liu X; Li W; Huang M; Zhao X; Ji D; Li J; Guo W
Acta Biochim Biophys Sin (Shanghai); 2021 Apr; 53(5):547-557. PubMed ID: 33693450
[TBL] [Abstract][Full Text] [Related]
22. MET amplification is not rare and predicts unfavorable clinical outcomes in patients with recurrent/metastatic gastric cancer after chemotherapy.
An X; Wang F; Shao Q; Wang FH; Wang ZQ; Wang ZQ; Chen C; Li C; Luo HY; Zhang DS; Xu RH; Li YH
Cancer; 2014 Mar; 120(5):675-82. PubMed ID: 24804300
[TBL] [Abstract][Full Text] [Related]
23. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
[TBL] [Abstract][Full Text] [Related]
24. [Study of gastric carcinoma and PCNA and c-met gene abnormality].
Ji J; Zhao P; Huang B
Wei Sheng Yan Jiu; 2008 Jul; 37(4):479-82. PubMed ID: 18839537
[TBL] [Abstract][Full Text] [Related]
25. Relationship of C-erbB-2 protein expression and gene amplification to invasion and metastasis in human gastric cancer.
Mizutani T; Onda M; Tokunaga A; Yamanaka N; Sugisaki Y
Cancer; 1993 Oct; 72(7):2083-8. PubMed ID: 8397058
[TBL] [Abstract][Full Text] [Related]
26. Overexpression of c-erb-B2 proteins in tumor and non-tumor parts of gastric adenocarcinoma--emphasis on its relation to H. pylori infection and clinicohistological characteristics.
Wang YL; Sheu BS; Yang HB; Lin PW; Chang YC
Hepatogastroenterology; 2002; 49(46):1172-6. PubMed ID: 12143229
[TBL] [Abstract][Full Text] [Related]
27. The prognostic impact of EGFR, ErbB2 and MET gene amplification in human gastric carcinomas as measured by quantitative Real-Time PCR.
Janbabai G; Oladi Z; Farazmandfar T; Taghvaei T; Naghshvar F
J Cancer Res Clin Oncol; 2015 Nov; 141(11):1945-52. PubMed ID: 25820598
[TBL] [Abstract][Full Text] [Related]
28. HER2-positive gastric cancer with concomitant MET and/or EGFR overexpression: a distinct subset of patients for dual inhibition therapy.
Ha SY; Lee J; Jang J; Hong JY; Do IG; Park SH; Park JO; Choi MG; Sohn TS; Bae JM; Kim S; Kim M; Kim S; Park CK; Kang WK; Kim KM
Int J Cancer; 2015 Apr; 136(7):1629-35. PubMed ID: 25157953
[TBL] [Abstract][Full Text] [Related]
29. c-erbB-2 is of independent prognostic relevance in gastric cancer and is associated with the expression of tumor-associated protease systems.
Allgayer H; Babic R; Gruetzner KU; Tarabichi A; Schildberg FW; Heiss MM
J Clin Oncol; 2000 Jun; 18(11):2201-9. PubMed ID: 10829039
[TBL] [Abstract][Full Text] [Related]
30. The Prognostic Significance of c-MET and EGFR Overexpression in Resected Gastric Adenocarcinomas.
Paliga A; Marginean H; Tessier-Cloutier B; Purgina B; Jonker D; Marginean EC
Am J Clin Oncol; 2017 Dec; 40(6):543-551. PubMed ID: 26125303
[TBL] [Abstract][Full Text] [Related]
31. The prognostic value of p53 and c-erb B-2 immunostaining is overrated for patients with lymph node negative breast carcinoma: a multivariate analysis of prognostic factors in 613 patients with a follow-up of 14-30 years.
Reed W; Hannisdal E; Boehler PJ; Gundersen S; Host H; Marthin J
Cancer; 2000 Feb; 88(4):804-13. PubMed ID: 10679650
[TBL] [Abstract][Full Text] [Related]
32. EGFR and AKT1 overexpression are mutually exclusive and associated with a poor survival in resected gastric adenocarcinomas.
Petrini I; Lencioni M; Vasile E; Fornaro L; Belluomini L; Pasquini G; Ginocchi L; Caparello C; Musettini G; Vivaldi C; Caponi S; Ricci S; Proietti A; Fontanini G; Naccarato AG; Nardini V; Santi S; Falcone A
Cancer Biomark; 2018 Feb; 21(3):731-741. PubMed ID: 29278885
[TBL] [Abstract][Full Text] [Related]
33. The relationship between c-erbB-2 oncogene expression and clinicopathological factors in gastric cancer.
Gürel S; Dolar E; Yerci O; Samli B; Oztürk H; Nak SG; Gülten M; Memik F
J Int Med Res; 1999; 27(2):74-8. PubMed ID: 10446693
[TBL] [Abstract][Full Text] [Related]
34. Expression of c-erb B-2 oncoprotein in cancer of the larynx in relation to invasion of the cartilagenous framework and prognosis.
Tantawy A; Youins L; Hamza M
Eur Arch Otorhinolaryngol; 1999; 256(2):72-7. PubMed ID: 10068894
[TBL] [Abstract][Full Text] [Related]
35. Amplification of growth factor receptor genes and DNA ploidy pattern in the progression of gastric cancer.
Tsujimoto H; Sugihara H; Hagiwara A; Hattori T
Virchows Arch; 1997 Dec; 431(6):383-9. PubMed ID: 9428926
[TBL] [Abstract][Full Text] [Related]
36. Analysis of MET mRNA expression in gastric cancers using RNA in situ hybridization assay: its clinical implication and comparison with immunohistochemistry and silver in situ hybridization.
Choi J; Lee HE; Kim MA; Jang BG; Lee HS; Kim WH
PLoS One; 2014; 9(11):e111658. PubMed ID: 25364819
[TBL] [Abstract][Full Text] [Related]
37. TNK2 gene amplification is a novel predictor of a poor prognosis in patients with gastric cancer.
Shinmura K; Kiyose S; Nagura K; Igarashi H; Inoue Y; Nakamura S; Maeda M; Baba M; Konno H; Sugimura H
J Surg Oncol; 2014 Mar; 109(3):189-97. PubMed ID: 24178904
[TBL] [Abstract][Full Text] [Related]
38. MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcome.
Lee HE; Kim MA; Lee HS; Jung EJ; Yang HK; Lee BL; Bang YJ; Kim WH
Br J Cancer; 2012 Jul; 107(2):325-33. PubMed ID: 22644302
[TBL] [Abstract][Full Text] [Related]
39. Prognostic significance of MET amplification and expression in gastric cancer: a systematic review with meta-analysis.
Peng Z; Zhu Y; Wang Q; Gao J; Li Y; Li Y; Ge S; Shen L
PLoS One; 2014; 9(1):e84502. PubMed ID: 24416238
[TBL] [Abstract][Full Text] [Related]
40. MET Gene Amplification and Overexpression in Chinese Non-Small-Cell Lung Cancer Patients Without EGFR Mutations.
Song Z; Wang X; Zheng Y; Su H; Zhang Y
Clin Lung Cancer; 2017 Mar; 18(2):213-219.e2. PubMed ID: 28322191
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
